Brown-Forman Reports Q2 Earnings Below Expectations, Year-over-Year Gross Margin Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 04 2025
0mins
Should l Buy CELH?
Source: NASDAQ.COM
Mixed Financial Results: Brown-Forman Corporation reported a mixed second-quarter fiscal 2026, with net sales of $1.036 billion beating estimates but earnings per share of 47 cents missing expectations, reflecting a year-over-year decline in both sales and earnings.
Market Performance: Despite the challenges, Brown-Forman's shares have increased by 4.1% over the past three months, contrasting with a 2.4% drop in the industry.
Sales Trends: The company experienced a 9% decline in net sales in the U.S. and a 4% drop in Developed International markets, while Emerging markets saw a 10% increase, driven by strong growth in specific brands.
Future Outlook: Management anticipates continued challenges in fiscal 2026, projecting low-single digit declines in organic net sales and operating income, while also committing to long-term growth strategies through innovation and restructuring.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CELH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CELH
Wall Street analysts forecast CELH stock price to rise
17 Analyst Rating
14 Buy
2 Hold
1 Sell
Strong Buy
Current: 47.110
Low
45.00
Averages
62.85
High
80.00
Current: 47.110
Low
45.00
Averages
62.85
High
80.00
About CELH
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Celsius Growth Slows as Alani Nu Drives Revenue Surge
- Core Brand Growth Slows: The organic growth of the Celsius brand has cooled to 7.5%, primarily due to distribution shifts, indicating that the brand has reached high domestic penetration and faces limited future growth potential.
- Impact of Alani Nu Acquisition: The acquisition of Alani Nu significantly boosted Celsius's revenue, achieving a 117% year-over-year increase in Q4 2025, highlighting the brand's strong performance in the health beverage market.
- Record Revenue Achievement: Celsius Holdings recorded $2.5 billion in revenue for Q4 2025, and despite the slowdown in core brand growth, the contribution from Alani Nu helped maintain robust financial performance for the company.
- Importance of Multi-Brand Strategy: With the success of Alani Nu, Celsius's future strategy will increasingly rely on a multi-brand platform, indicating a shift towards a high-margin integration as the core growth engine.
See More
Celsius Holdings Q4 Results Indicate Shift in Growth Dynamics
- Brand Growth Slowdown: The Celsius brand experienced a decline in organic growth to 7.5% in Q4 2025, indicating that distribution shifts are impacting performance and could lead to market share fluctuations.
- Record Revenue: Despite the slowdown in core brand growth, the company achieved a record $2.5 billion in revenue, demonstrating its strong market position and resilience in the beverage sector.
- Alani Nu's Rise: The newly acquired Alani Nu exploded in late 2025, generating over $1 billion in annual revenue, becoming the new growth driver for the company and indicating the effectiveness of Celsius's multi-brand strategy.
- Future Growth Potential: As 2026 approaches, Alani Nu's high-margin integration positions it as Celsius's
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More
Celsius Reports Strong Earnings Post-Alani Nu Acquisition
- Revenue Surge: Celsius reported a pro forma revenue increase of 136% to $370 million, driven by Alani Nu, with overall sales soaring 117% to $721.6 million, indicating strong growth potential in the beverage market.
- Brand Performance Discrepancy: While Celsius brand revenue fell 7.7%, Alani Nu's retail sales surged 76.9%, and Rockstar contributed $45 million in sales, reflecting initial success in brand integration and shifting market demands.
- Profitability Improvement: Adjusted earnings per share (EPS) jumped 86% to $0.26, and adjusted EBITDA climbed 113% to $134.1 million, showcasing significant enhancements in profitability, with expectations for further gross margin improvements.
- Market Expansion Plans: Celsius aims to expand its international presence, currently in 10 markets, anticipating increased shelf space, particularly following the distribution transition with PepsiCo, which will further enhance brand global reach.
See More
Celsius Sees Strong Growth Driven by Alani Nu
- Revenue Surge: Celsius's revenue surged 136% to $370 million driven by Alani Nu, with overall sales soaring 117% to $721.6 million, indicating strong market demand and brand appeal.
- Profitability Improvement: Adjusted earnings per share (EPS) jumped 86% to $0.26, while adjusted EBITDA climbed 113% to $134.1 million, reflecting significant progress in cost control and operational efficiency.
- Market Expansion Plans: Celsius plans to expand its international presence, currently in 10 markets, and aims to drive further growth through increased shelf space and the launch of a non-carbonated line.
- Valuation Reasonable: The stock trades at about 34 times 2026 analyst estimates, which is considered reasonable given its strong growth potential, although investors should be cautious as growth may slow in the future.
See More
Celsius Growth Slows as Alani Nu Drives Revenue Surge
- Core Brand Growth Slows: The organic growth of the Celsius brand has cooled to 7.5%, primarily due to distribution shifts, indicating that the brand has reached high domestic penetration and faces limited future growth potential.
- Impact of Alani Nu Acquisition: The acquisition of Alani Nu significantly boosted Celsius's revenue, achieving a 117% year-over-year increase in Q4 2025, highlighting the brand's strong performance in the health beverage market.
- Record Revenue Achievement: Celsius Holdings recorded $2.5 billion in revenue for Q4 2025, and despite the slowdown in core brand growth, the contribution from Alani Nu helped maintain robust financial performance for the company.
- Importance of Multi-Brand Strategy: With the success of Alani Nu, Celsius's future strategy will increasingly rely on a multi-brand platform, indicating a shift towards a high-margin integration as the core growth engine.
See More
Celsius Holdings Q4 Results Indicate Shift in Growth Dynamics
- Brand Growth Slowdown: The Celsius brand experienced a decline in organic growth to 7.5% in Q4 2025, indicating that distribution shifts are impacting performance and could lead to market share fluctuations.
- Record Revenue: Despite the slowdown in core brand growth, the company achieved a record $2.5 billion in revenue, demonstrating its strong market position and resilience in the beverage sector.
- Alani Nu's Rise: The newly acquired Alani Nu exploded in late 2025, generating over $1 billion in annual revenue, becoming the new growth driver for the company and indicating the effectiveness of Celsius's multi-brand strategy.
- Future Growth Potential: As 2026 approaches, Alani Nu's high-margin integration positions it as Celsius's
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More
Celsius Reports Strong Earnings Post-Alani Nu Acquisition
- Revenue Surge: Celsius reported a pro forma revenue increase of 136% to $370 million, driven by Alani Nu, with overall sales soaring 117% to $721.6 million, indicating strong growth potential in the beverage market.
- Brand Performance Discrepancy: While Celsius brand revenue fell 7.7%, Alani Nu's retail sales surged 76.9%, and Rockstar contributed $45 million in sales, reflecting initial success in brand integration and shifting market demands.
- Profitability Improvement: Adjusted earnings per share (EPS) jumped 86% to $0.26, and adjusted EBITDA climbed 113% to $134.1 million, showcasing significant enhancements in profitability, with expectations for further gross margin improvements.
- Market Expansion Plans: Celsius aims to expand its international presence, currently in 10 markets, anticipating increased shelf space, particularly following the distribution transition with PepsiCo, which will further enhance brand global reach.
See More
Celsius Sees Strong Growth Driven by Alani Nu
- Revenue Surge: Celsius's revenue surged 136% to $370 million driven by Alani Nu, with overall sales soaring 117% to $721.6 million, indicating strong market demand and brand appeal.
- Profitability Improvement: Adjusted earnings per share (EPS) jumped 86% to $0.26, while adjusted EBITDA climbed 113% to $134.1 million, reflecting significant progress in cost control and operational efficiency.
- Market Expansion Plans: Celsius plans to expand its international presence, currently in 10 markets, and aims to drive further growth through increased shelf space and the launch of a non-carbonated line.
- Valuation Reasonable: The stock trades at about 34 times 2026 analyst estimates, which is considered reasonable given its strong growth potential, although investors should be cautious as growth may slow in the future.
See More
